NCT00391144

Avastin for CNV Secondary to Pattern Dystrophy

Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 5 (planned)
• Sponsor: University of Trieste · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The natural history of subfoveal CNV secondary to Pattern Dystrophy is little understood, but it seems that visual function may be preserved only in the short-term follow-up, with progressive deterioration thereafter. Photodynamic therapy with verteporfin is the most studied therapeuthic option for this kindf of lesion, but unfortunately, this approach does not appear to guarantee long-term vision stabilization, and alternative therapies should be investigated.

Detailed description

Diagnosis of Pattern Dystrophy Diagnosis of subfoveal CNV Intravitreal injection of avastin (1.25 mg) in operating room under sterile condition. Retreatment on the basis of the detection of disease progression and of lack of central retinal thickness reduction on OCT.

Conditions

• Choroidal Neovascularization Secondary to Pattern Dystrophy

Interventions

Type	Name	Description
PROCEDURE	intravitreal triamcinolone injection of avastin (1.25 mg)

Timeline

• Start date: 2006-07-01
• Completion: 2006-10-01
• First posted: 2006-10-23
• Last updated: 2006-10-23

Locations

1 site across 1 country: Italy